Cargando…
Novel Ellipsoid Chitosan-Phthalate Lecithin Nanoparticles for siRNA Delivery
Small interfering RNA (siRNA) has received increased interest as a gene therapeutic agent. However, instability and lack of safe, affordable, and effective carrier systems limit siRNA's widespread clinical use. To tackle this issue, synthetic vectors such as liposomes and polymeric nanoparticle...
Autores principales: | Saeed, Ramzi Mukred, Abdullah, Mohammed, Ahram, Mamoun, Taha, Mutasem Omar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355739/ https://www.ncbi.nlm.nih.gov/pubmed/34395401 http://dx.doi.org/10.3389/fbioe.2021.695371 |
Ejemplares similares
-
Stable Chitosan-Based Nanoparticles Using Polyphosphoric Acid or Hexametaphosphate for Tandem Ionotropic/Covalent Crosslinking and Subsequent Investigation as Novel Vehicles for Drug Delivery
por: Saeed, Ramzi Mukred, et al.
Publicado: (2020) -
Potential of siRNA in COVID-19 therapy: Emphasis on in silico design and nanoparticles based delivery
por: Fopase, Rushikesh, et al.
Publicado: (2023) -
Optimizing the Intracellular Delivery of Therapeutic Anti-inflammatory TNF-α siRNA to Activated Macrophages Using Lipidoid-Polymer Hybrid Nanoparticles
por: Lokras, Abhijeet, et al.
Publicado: (2021) -
Selection and Validation of siRNAs Preventing Uptake and Replication of SARS-CoV-2
por: Friedrich, Maik, et al.
Publicado: (2022) -
Identification of nanoparticle-mediated siRNA-ASPN as a key gene target in the treatment of keloids
por: Dong, Yipeng, et al.
Publicado: (2022)